Effects of Parenteral Nutrition With Different Lipid Emulsions in Preterm Infants
NCT01683162 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2012-09-18
Summary
Previous studies have suggested that olive oil-based emulsion is safe and well tolerated in preterm infants, a showed efficacy and a good clinical and biological safety profile. The objective of this study was to assess the effects of a new olive-oil based lipid emulsion compared with the traditional lipid emulsions.
Conditions
- Preterm Infant
Interventions
- DRUG
-
ClinOleic
the lipid of all-in-one, 0.5-3.5g/kg.d
- DRUG
-
Lipofundin
the lipid of all-in-one, 0.5-3.5g/kg.d
- DRUG
-
Intralipid
the lipid of all-in-one, 0.5-3.5g/kg.d
Sponsors & Collaborators
-
Wei Cai
lead OTHER
Principal Investigators
-
Ying Wang, phd · Xin Hua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai,China
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Day
- Max Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-07-31
- Primary Completion
- 2012-12-31
- Completion
- 2013-02-28
Countries
- China
Study Locations
More Related Trials
-
Safety and Efficacy of Addition of Structured Lipids in Starter Formulas
NCT02332967 ·Status: COMPLETED ·Phase: NA
-
Effects of Specific Lipid Fractions-enriched Infant Formulae
NCT02111837 ·Status: COMPLETED ·Phase: NA
-
Early Provision of Enteral Microlipid and Fish Oil to Infants With Enterostomy
NCT01306838 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Lipid Infusions to Optimize Nutrition Trial
NCT06915441 ·Status: RECRUITING ·Phase: PHASE2
-
Protocol for Feeding Intolerance in Preterm Infants
NCT05347706 ·Status: UNKNOWN ·Phase: NA
-
Influence of Physical Treatments of Human Milk on the Kinetics of Gastric Lipolysis in Preterm Newborns
NCT02112331 ·Status: COMPLETED ·Phase: NA
-
Early Supplementation of Enteral Microlipid With and Without Fish Oil in Premature Infants With Enterostomies
NCT01674478 ·Status: COMPLETED ·Phase: PHASE2
-
Low Dose Parenteral Fat for Prevention of Parenteral Nutrition Associated Cholestasis in Preterm Neonates
NCT01050660 ·Status: COMPLETED ·Phase: NA
-
Tolerance of Healthy Infants Fed Infant Formulas
NCT02401217 ·Status: COMPLETED ·Phase: NA
-
Vitamin E for Extremely Preterm Infants
NCT01193270 ·Status: COMPLETED ·Phase: PHASE1
-
Donor Milk vs. Formula in Extremely Low Birth Weight (ELBW) Infants
NCT01534481 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects on Growth and Tolerance of a Routine Infant Formula Fed to Term Infants
NCT02132663 ·Status: COMPLETED ·Phase: NA
-
Effect of a Mix of Dairy Lipids and Plant Oils in Infant Formula on Omega-3 Fatty Acid in Red Blood Cells
NCT01611649 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Formula on Infant Behavior
NCT02746016 ·Status: COMPLETED ·Phase: NA
-
Nutritional Study in Preterm Infants
NCT00707837 ·Status: COMPLETED ·Phase: PHASE3
-
Tolerance of Healthy Term Infants Fed Infant Formulas #4
NCT01155414 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Formula on Growth of Infants From Overweight or Obese Mothers
NCT00820833 ·Status: COMPLETED ·Phase: NA
-
Preventing Cholestasis Using SMOFLipid®
NCT01585935 ·Status: COMPLETED ·Phase: PHASE4
-
Tolerance of Healthy Term Infants Fed Infant Formulas #3
NCT00977964 ·Status: COMPLETED ·Phase: PHASE3
-
Re-feeding Gastric Residuals in Preterm Infants
NCT01420263 ·Status: COMPLETED ·Phase: NA
-
Investigation of Administration of MCT/ω-3 Fatty Acids is Towards Anti-inflammatory Related Fatty Acid Profile in Preterm Neonates.
NCT04586608 ·Status: COMPLETED ·Phase: NA
-
Effects of Enteral Feeding Regimens on NEC, Mortality, and Neurodevelopment in Very Preterm Infants
NCT07045844 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Growth and Tolerance of Young Infants Fed Infant Formulas
NCT01380886 ·Status: COMPLETED ·Phase: PHASE3
-
Tolerance and Digestibility of a New Formula in Healthy Infants
NCT01184378 ·Status: COMPLETED ·Phase: PHASE2
-
Metabolic Effects of Choline and Docosahexaenoic Acid Supplementation in Preterm Infants
NCT02509728 ·Status: COMPLETED ·Phase: NA